Nanoscale, 2015, Accepted Manuscript
DOI: 10.1039/C5NR01172H, Paper
DOI: 10.1039/C5NR01172H, Paper
Zaixing Yang, Cuicui Ge, Jiajia Liu, Yu Chong, Zonglin Gu, Camilo A. Jimenez-Cruz, Zhifang Chai, Ruhong Zhou
Current therapies for Alzheimer's disease (AD) can provide a moderate symptomatic reduction or delay progression at various stages of the disease, but such treatments ultimately do not arrest the advancement...
The content of this RSS Feed (c) The Royal Society of Chemistry
Current therapies for Alzheimer's disease (AD) can provide a moderate symptomatic reduction or delay progression at various stages of the disease, but such treatments ultimately do not arrest the advancement...
The content of this RSS Feed (c) The Royal Society of Chemistry
Click for full article
No comments:
Post a Comment